Orchestra BioMed Holdings, Inc.

Healthcare · Biotechnology · United States

Last price 6.09 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 366.04M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Orchestra BioMed Holdings, Inc. operates as a biomedical company in the United States. The company’s flagship product candidates include Atrioventricular Interval Modulation, a bioelectronic therapy candidate designed to immediately, substantially, and persistently lower blood pressure; and Virtue Sirolimus AngioInfusion Balloon for the treatment of atherosclerotic artery disease. It also develops Cardiac Neuromodulation Therapy for heart failure, or potential treatment of clinical indications, such as urology or osteoarthritis; and CNT-HF, a b...